Regulatory Scrutiny Intensifies as Tanning Peptide Melanotan II Faces FDA Review

By Kara Nesvig · Allure · 2026-07-09

Allure reports that the FDA Pharmacy Compounding Advisory Committee is set to evaluate the status of Melanotan II, an unapproved synthetic peptide frequently sold on the gray market. Often marketed as the Barbie drug, this substance mimics hormones to stimulate melanin production

Allure reports that the FDA Pharmacy Compounding Advisory Committee is set to evaluate the status of Melanotan II, an unapproved synthetic peptide frequently sold on the gray market. Often marketed as the Barbie drug, this substance mimics hormones to stimulate melanin production